T E Adrian
Overview
Explore the profile of T E Adrian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
339
Citations
4309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Howarth F, Qureshi M, Jayaprakash P, Parekh K, Oz M, Dobrzynski H, et al.
J Diabetes Res
. 2018 Sep;
2018:8454078.
PMID: 30246030
Background: experiments in Goto-Kakizaki (GK) type 2 diabetic rats have demonstrated reductions in heart rate from a young age. The expression of genes encoding more than 70 proteins that are...
2.
Sajwani F, Collin P, Adrian T
Leuk Res
. 2017 Nov;
63:98-108.
PMID: 29127862
Acute leukemia is the major cause of mortality in hematological malignancies. Despite improvement of survival with current chemotherapies, patients die from the disease or side-effects of treatment. Thus, new therapeutic...
3.
Gaber E, Jayaprakash P, Qureshi M, Parekh K, Oz M, Adrian T, et al.
Exp Physiol
. 2014 Apr;
99(6):881-93.
PMID: 24681897
There has been a spectacular rise in the global prevalence of type 2 diabetes mellitus (T2DM), and cardiovascular disease is the major cause of morbidity and mortality in diabetic patients....
4.
Al Shemaili J, Mensah-Brown E, Parekh K, Thomas S, Attoub S, Hellman B, et al.
Eur J Cancer
. 2014 Jan;
50(7):1391-8.
PMID: 24462376
Pancreatic cancer has a very poor prognosis. While gemcitabine is the mainstay of therapy and improves quality of life, it has little impact on survival. More effective treatments are desperately...
5.
Salem K, Qureshi M, Sydorenko V, Parekh K, Jayaprakash P, Iqbal T, et al.
Mol Cell Biochem
. 2013 Apr;
380(1-2):83-96.
PMID: 23620341
Although, several novel forms of intervention aiming at newly identified therapeutic targets are currently being developed for diabetes mellitus (DM), it is well established that physical exercise continues to be...
6.
Adrian T, Gariballa S, Parekh K, Thomas S, Saadi H, Al Kaabi J, et al.
Diabetologia
. 2012 Jun;
55(9):2343-7.
PMID: 22696033
Aims/hypothesis: Glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) are secreted from enteroendocrine L cells in response to numerous stimuli, including bile salts. Both have multiple effects that are potentially useful...
7.
Salem K, Adrian T, Qureshi M, Parekh K, Oz M, Howarth F
Exp Physiol
. 2012 May;
97(12):1281-91.
PMID: 22581745
There has been a spectacular rise in the global prevalence of type 2 diabetes mellitus. Cardiovascular complications are the major cause of morbidity and mortality in diabetic patients. Contractile dysfunction,...
8.
Howarth F, Qureshi M, Hassan Z, Isaev D, Parekh K, John A, et al.
Mol Cell Biochem
. 2011 Oct;
361(1-2):267-80.
PMID: 22009485
There has been a spectacular rise in the global prevalence of type 2 diabetes mellitus and cardiovascular complications are the major cause of morbidity and mortality in diabetic patients. The...
9.
Howarth F, Qureshi M, Hassan Z, Al Kury L, Isaev D, Parekh K, et al.
Exp Physiol
. 2011 Jan;
96(3):325-37.
PMID: 21216827
The association between type 2 diabetes and obesity is very strong, and cardiovascular complications are the major cause of morbidity and mortality in diabetic patients. The aim of this study...
10.
Li X, Roginsky A, Ding X, Woodward C, Collin P, Newman R, et al.
Ann N Y Acad Sci
. 2008 Oct;
1138:181-98.
PMID: 18837899
Pancreatic cancer cells are resistant to the growth-inhibitory and apoptosis-inducing effects of conventional chemotherapeutic agents. There are multiple genetic and epigenetic events during the process of carcinogenesis that enable the...